4Patterson TF, Kirkpatfick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes [ J]. Medicine (Baltimore) , 2000, 79 : 250-260.
5Siddiqui AA, Shah AA, Bashir SH. Craniocerebral aspergillosis of sinonasal origin in immunocompetent patients: clinical spectrum and outcome in 25 cases [ J]. Neurosurgery, 2004, 55: 602-611.
6Brun S, Fekkar A, Busse A, et al. Aspergillus flavus brain abscesses associated with hepatic amebiasis in a non-neutropenic man in Senegal [J]. Am J Trop Med Hyg, 2009, 81 (5) : 583-586.
7Walsh TJ, Anaissie E J, Denning DW, et al. Infectious Diseases Society of America. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America [ J ]. Clin Infect Dis 2008, 46 (4) : 327-360.
9Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature [ J]. Clin Infect Dis, 2001, 32 (3) : 358-366.
10Schwartz S, Ruhnke M, Ribaud P, et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment [J]. Blood, 2005, 106 (23) : 2641-2645.
7Finch R.Gram-positive infections lessons learnt and novel solutions[J].Clin Microbiol Infect,2006,12(Supp18):3-8.
8Esposito S,Noviello S,Leone S,et al.A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones[J].Chemother,2006,18(5):494-501.
10De Pauw B, Walsh RJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the european organization for research and treatment of cancer/lnvasivef[J]. Clin lnfect Dis, 2008,46 (12) :1813-1821.
